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RESEARCH ARTICLE Open Access
Intronic Non-CG DNA hydroxymethylation and
alternative mRNA splicing in honey bees
Pablo Cingolani1,2†, Xiaoyi Cao3†, Radhika S Khetani3†, Chieh-Chun Chen3, Melissa Coon1, Alya’a Sammak1,
Aliccia Bollig-Fischer5, Susan Land1, Yun Huang6, Matthew E Hudson3,4, Mark D Garfinkel7, Sheng Zhong3,
Gene E Robinson3,8,9 and Douglas M Ruden1,10*
Abstract
Background: Previous whole-genome shotgun bisulfite sequencing experiments showed that DNA cytosine
methylation in the honey bee (Apis mellifera) is almost exclusively at CG dinucleotides in exons. However, the most
commonly used method, bisulfite sequencing, cannot distinguish 5-methylcytosine from 5-hydroxymethylcytosine,
an oxidized form of 5-methylcytosine that is catalyzed by the TET family of dioxygenases. Furthermore, some
analysis software programs under-represent non-CG DNA methylation and hydryoxymethylation for a variety of
reasons. Therefore, we used an unbiased analysis of bisulfite sequencing data combined with molecular and
bioinformatics approaches to distinguish 5-methylcytosine from 5-hydroxymethylcytosine. By doing this, we have
performed the first whole genome analyses of DNA modifications at non-CG sites in honey bees and correlated the
effects of these DNA modifications on gene expression and alternative mRNA splicing.
Results: We confirmed, using unbiased analyses of whole-genome shotgun bisulfite sequencing (BS-seq) data, with
both new data and published data, the previous finding that CG DNA methylation is enriched in exons in honey
bees. However, we also found evidence that cytosine methylation and hydroxymethylation at non-CG sites is
enriched in introns. Using antibodies against 5-hydroxmethylcytosine, we confirmed that DNA hydroxymethylation
at non-CG sites is enriched in introns. Additionally, using a new technique, Pvu-seq (which employs the enzyme
PvuRts1l to digest DNA at 5-hydroxymethylcytosine sites followed by next-generation DNA sequencing), we further
confirmed that hydroxymethylation is enriched in introns at non-CG sites.
Conclusions: Cytosine hydroxymethylation at non-CG sites might have more functional significance than previously
appreciated, and in honey bees these modifications might be related to the regulation of alternative mRNA splicing
by defining the locations of the introns.
Keywords: Honey Bees, DNA methylation, DNA hydroxymethylation, Epigenetics
Background
Methylation of DNA is increasingly appreciated as a potent
way to regulate gene expression, but a comprehensive un-
derstanding of the diversity of methylation mechanisms has
not yet been achieved. For example, methylation that does
not occur at cytosine-guanosine dinucleotide sequences
(non-CG methylation) is an underappreciated and poorly
understood form of epigenetic regulation. While rare in
mammalian somatic cells, non‐CG methylation occurs on
20‐40% of the cytosines in human embryonic stem cells
(hESCs) [1,2], and is thought to be involved in pluripotency
[1]. A recent comparative analysis of DNA methylation
across hESC lines found that heavily methylated non‐CG
sites are strongly conserved, especially within the motif
TAmCAG at 3’ splice junctions [2], suggesting a role in spli-
cing or alternative splicing of mRNA transcripts. Also,
CTCF induced RNA polymerase II pausing was shown to
link alternative mRNA splicing to DNA methylation at a
CTCF binding site in genomic DNA encoding an intron
[3]. Recently it was shown that RNA interference
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knockdown of DNA methyltransferase 3 (Dnmt3) affects
gene alternative splicing in the honey bee [4].
The honey bee (Apis mellifera) is emerging as a new
model to study effects of methylation on genome function
because, unlike Drosophila melanogaster, it possesses a fully
functioning methylation system [5-7]. Three studies [6,8,9]
have reported that honey bees have CG methylation pri-
marily at exon coding regions, and we have confirmed
these studies here. These three studies have also reported
that honey bees have little, if any, non-CG methylation
[6,8,9]. However, since all three of the previous studies’
experimental design filtered out much of the non-CG
methylation ([6,8,9] and personal communication; see Ac-
knowledgements), it is still an open question as to whether
there are significant amounts of non-CG methylation in
bees. The are several reasons for filtering out non-CG
methylation: (1) non-CG methylation is much less abun-
dant than CG methylation in mammals; (2) there are sev-
eral times more non-CG sequences (i.e., CA, CT, and CC)
than CG sequences, and focusing analyses on CG methyla-
tion is simpler; (3) non-CG methylation is often in less
complex regions of the genome, such as introns, and is
therefore difficult to map with short-read next-generation
sequencing technology; and (4) since bisulfite works less
well on double-stranded DNA than single-stranded DNA,
less complex regions might form snap-back structures that
are resistant to bisulfite conversion.
Hydroxymethylation of DNA is a newly discovered
form of epigenetic regulation. It has been found recently
in embryonic stem cells (ESC) and in the brains of mam-
mals [10,11]. In mammals, TET proteins have been
shown to be dioxygenases that convert mC to 5-
hydroxymethylcytosine (hmC). Honey bees have a TET
ortholog [10,12], but hmC has not yet been reported.
Genome-wide wide mapping in mouse ESCs has re-
vealed that hmC is enriched at the start sites of genes
whose promoters bear histone 3 lysine 27 trimethylation
(H3K27me3) and histone 3 lysine 4 trimethylation
(H3K4me3) marks [13-18]. In human ESCs, this dual
mark is derived from separable subpopulations of self-
renewing and lineage-biased ESCs within the heteroge-
neous unfractionated ESC population [19].
The most common chemical approach to study DNA
methylation is treating single-stranded DNA with bisul-
fite, but bisulfite cannot distinguish mC from hmC be-
cause both base-pair as cytosine after bisulfite treatment.
The modification mC mostly remains in this form after
bisulfite treatment, whereas hmC is converted to cytosine
methylene sulfonate (CMS) after bisulfite treatment,
which has the same hydrogen bond donor and acceptor
configuration as cytosine for base pairing to guanine
[10]. In this paper, in addition to whole-genome shotgun
bisulfite sequencing of honey bee head DNA, we devel-
oped new biochemical and bioinformatics tools to
analyze non-CG methylation and hydroxymethylation.
We sharpened our analyses by comparing bees endemic
to North America that are derived from a mixture of
European subspecies of Apis mellifera (“EHB”) with bees
derived from the African subspecies Apis mellifera
scutallata, introduced to South America in the last cen-
tury (“AHB”). EHB and AHB are attractive candidates
for comparative molecular analysis because they differ in
many physiological and behavioral traits, including ag-
gression. Differences in methylation between EHB and
AHB that are reported here may be related to these
physiological and behavioral differences, and could motivate
further studies, beyond the scope of the present paper. We
show that non-CG methylation and hydroxymethylation
are both enriched in introns, and cytosine modification at
splice junctions might help regulate alternative splicing and
gene expression.
Results and discussion
We asked whether non-CG methylation and hydro-
xymethylation occurs in honey bees using unbiased ap-
proaches that do not filter out non-CG methylation. We
compared AHB and EHB mainly to demonstrate the ro-
bustness of our experimental and bioinformatics ap-
proaches. To standardize our comparisons, we analyzed
head methylomes only from AHB and EHB “guard” bees,
a specialized group of individuals that patrol the hive en-
trance and respond first to a threat to their colony. Most
of the tissues in the bee head consist of brain.
Whole-genome shotgun bisulfite sequencing validates
that CG methylation is primarily located in the exons
We performed whole-genome shotgun sequencing of bi-
sulfite modified DNA (BS-Seq) from AHB and EHB
heads and obtained over 20× coverage of both genomes
(Table 1; Additional file 1: Figure S1; see Methods). All
four of the honey bee BS-Seq studies conducted to date —
three published studies [6,8,9], and our experiments
reported here — identified ~5-10× more CG methyla-
tion in exons than in introns. In the present study, there
was ~6% CG methylation in exons and ~1% in introns
and intergenic regions in EHB, compared with ~3% and
~0.3%, respectively in AHB (Table 2). Similarly, our re-
analysis of the data from ref. [6] identified ~8% CG
methylation in exons and ~0.3% methylation in introns
in EHB (AHB was not studied; Additional file 2: Table
S1). Only 15% (AHB) to 21% (EHB) of the CG methyla-
tion is symmetrically methylated in honey bees (Table 1),
which is lower than what is observed in mammals (over
90%). Our analysis methods, which we call BS-Miner
(See Methods), are sensitive to non-CG sites and identify
hemi-methylated DNA using algorithms analogous to
those by which heterozygous DNA sequences are identi-
fied in whole-genome sequences [20]. Recently, a BS-seq
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analysis tool called Bismark was developed that does not
filter out non-CG methylation [21]. The amount of CHH
and CHG methylation identified in the ref. [6] dataset by
Bismark was approximately the same as the amount of
CG methylation (516,148 versus 540,208, Additional file 2:
Table S2), which is consistent with our analyses of our
AHB and EHB datasets that show much more CHH and
CHG methylation than previously reported.
Whole-genome shotgun bisulfite sequencing identifies
non-CG modifications that are enriched in introns
As in the previous studies [6,8,9], we determined that
CG methylation is primarily in the exons. However, a
second finding from our analyses of both our data and
the data from ref. [6] is relatively high levels of non-CG
modifications (i.e., either mC or hmC) in bee heads. Sur-
prisingly, our methods detected about 5-fold more CHH
modifications (H = C, A, T) than CG methylation in
both AHB and EHB DNA (Table 1). As with the CG
methylation, we also saw more than twice as many non-
CG modifications in EHB than AHB heads. About 2.5%
of the total number of CHH sequences was modified in
EHB and about 1.1% in AHB (Table 1).
In order to validate our finding of high levels of non-CG
modifications, we reanalyzed previously published honey
bee data from ref. [6] with our methods and again found
that the amount of non-CG modifications exceeded the
amount of CG methylation (Additional file 2: Table S1).
Table 1 Differential cytosine DNA methylation between European (EHB) and Africanized (AHB) honey bees in CG, CHG,
and CHH genomic contexts (H = A, T, or C)
Total* Methylated in EHB (%) Methylated in AHB (%) Symmetrically methylated (%)
CG 10,030,209 (15%) 253,041 (2.5%) 94,248 (0.9%) 54,120 (21%, EHB), 14,454 (15%, AHB)
CHG 8,673,113 (14%) 80,295 (0.9%) 24,834 (0.3%) 423 (0.53%, EHB), 106 (0.43%, AHB)
CHH 45,072,611 (71%) 1,258,515 (2.8%) 519,318 (1.2%) 0%
Total 63,775,933 (100%) 1,591,851 (2.5%) 638,400 (1.1%) 54,543 (3.4%, EHB), 14,560 (2.3% AHB)
*The total number of cytosines represent both the uniquely mapped and the non-uniquely mapped cytosines (from [6]).
Table 2 DNA methylation at CpG sites in AHB and EHB
AHB CpG methylation by genetic region
Type (alphabetical order) Analyzed Methylated Methylated %
Cds 1,273,706 40,288 3.16%
Downstream 2,086,041 37,798 1.81%
Exon 1,273,706 40,288 3.16%
Gene 7,105,672 62,011 0.87%
Intergenic 9,767,537 35,409 0.36%
Intron 5,887,038 22,463 0.38%
SpliceSiteAcceptor 14 1 7.14%
SpliceSiteDonor 2,257 81 3.59%
Transcript 7,806,591 64,990 0.83%
Upstream 2,294,855 38,169 1.66%
EHB CpG methylation by genetic region
Type (alphabetical order) Analyzed Methylated Methylated %
Cds 1,318,533 82,558 6.26%
Downstream 2,255,737 89,512 3.97%
Exon 1,318,533 82,558 6.26%
Gene 7,555,968 149,371 1.98%
Intergenic 10,471,326 111,682 1.07%
Intron 6,293,493 68,460 1.09%
SpliceSiteAcceptor 18 1 5.56%
SpliceSiteDonor 2,504 215 8.59%
Transcript 8,297,751 158,204 1.91%
Upstream 2,468,142 87,960 3.56%
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The differences in the amounts of non-CG modifications
in our data compared with ref. [6] might be caused by bi-
sulfite treatment conditions (we did a single treatment
and they did multiple treatments) or differences in strains
of bees used in the two studies. We constructed the
Illumina libraries using the identical protocol as ref. [6]
which used unmethylated oligonucleotides, followed by
amplification of only bisulfite converted oligonucleotides,
to ensure that only fully bisulfite converted DNA is incor-
porated into the libraries (see Methods).
We also validated our data analysis pipelines by using
two recent independently developed bisulfite methylation
analysis program (BS-Map and Bismark) [21-23] on the
data from ref. [6] and were again able to identify non-CG
methylation sites (Additional file 2: Table S2 and Additional
file 1: Figure S2). These independent algorithms also found
more non-CG than CG methylation, consistent with our
findings.
In contrast to CG methylation, CHH modifications
were highest in introns (~4% and ~2% in EHB and
AHB) and lowest in exons (~2% and ~0.8% in EHB and
AHB) (Table 3). Consistent with this, our re-analysis of
the EHB data from ref. [6] identified ~4 times more
CHH modifications in introns than exons (2% versus
0.5%; Additional file 2: Table S1).
We also detected CHG modifications at levels lower than
both CG and CHH (~1.1% and ~0.3% in EHB and AHB,
Table 4). There was only about one-seventh as many CHG
modifications as CHH modifications, and very few of the
CHG modifications were symmetrical (~3.4% in EHB and
~2.3% in AHB, Table 2). CHG modifications were more
uniform across the genome than CG methylation or CHH
modifications (Table 2). Coverage for individual chromo-
somes (Additional file 1: Figure S3) demonstrates that there
were no significant biases toward any portion of the gen-
ome in the sequencing procedure.
Overall, EHB had almost 2.5× more modified Cs than
did AHB (1,591,851 versus 638,400). We also observed
~3-4-fold more CG methylation than in the previous
three studies: we detected 253,041 methylated CGs in
EHB, compared with 80,000-90,000 in the previous 3
studies (Table 2) [6,8,9]. This appears to be due to higher
sensitivity of the analysis program used; as stated above,
using our methods on data from ref. [6] identified
334,949 methylated CGs (Additional file 2: Table S1),
which is even more than we identified in our data. The
significance of EHB having 2.5× more modified Cs than
AHB is not known.
Bees have 5-hydroxymethylcytosine
BS-Seq cannot distinguish mC from hmC because both base
pair as C after BS treatment [10]. We used highly sensitive
anti-CMS antibodies [13] to determine the levels of hmC in
the heads and bodies of AHB and EHB. Consistent with
the BS-Seq results, we found comparable and statistically
indistinguishable levels of hmC in EHB and AHB heads
(15.2 pmol/μg and 13.5 pmol/μg of genomic DNA)
(Additional file 1: Figure S4). For bodies, there was signifi-
cantly more hmC in EHB than AHB (25.7 pmol/μg and 19.3
pmol/μg) (p < 0.05, 2-tailed t-test, Additional file 1:
Figure S4).
The 5-hydroxymethylcytosine in bees is enriched in
introns
To distinguish mC from hmC, we immunoprecipitated
honey bee head DNA with antibodies against 5-
hydroxymethylcytosine (HMeDIP). The immunopre-
cipitated DNA was then sequenced by next-generation
DNA sequencing (HMeDIP-seq). Compared to previ-
ous findings that mC is found primarily in exons, we
found that most of the hmC DNA is present in in-
trons (Table 5), where most of the non-CG modifica-
tions are also present. This leads to the speculation
that hmC is enriched in non-CG sites, and that many
Table 3 DNA methylation at CHH sites in AHB and EHB
AHB CHH modifications by genetic
region
Type (alphabetical order) Analyzed Methylated Methylated %
Cds 3,316,927 26,207 0.79%
Downstream 5,075,583 79,404 1.56%
Exon 3,316,927 26,207 0.79%
Gene 12,684,330 212,020 1.67%
Intergenic 16,317,387 325,139 1.99%
Intron 9,480,307 186,385 1.97%
SpliceSiteAcceptor 14,774 87 0.59%
SpliceSiteDonor 26,957 121 0.45%
Transcript 13,795,281 234,094 1.70%
Upstream 5,213,214 74,112 1.42%
EHB CHH modifications by genetic
region
Type (alphabetical order) Analyzed Methylated Methylated %
Cds 3,648,122 85,111 2.33%
Downstream 5,967,723 216,950 3.64%
Exon 3,648,122 85,111 2.33%
Gene 14,525,454 521,600 3.59%
Intergenic 19,011,050 773,971 4.07%
Intron 10,997,021 438,582 3.99%
SpliceSiteAcceptor 17,187 538 3.13%
SpliceSiteDonor 34,121 620 1.82%
Transcript 15,784,142 570,790 3.62%
Upstream 6,096,005 211,100 3.46%
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of the non-CG modifications that are detected by
whole genome bisulfite sequencing are actually hmC,
since bisulfite cannot distinguish mC from hmC.
Pvu-seq validates the location of hmC in introns
To validate the hmC findings, we developed a new
technique that we call Pvu-Seq. This technique
involves digesting the DNA isolated from AHB
and EHB heads with the Type 2 restriction endo-
nuclease, PvuRts1I, which cuts near single hydroxy-
methylcytosine sites [24-26]. The distances between
the cleavage sites and the modified cytosine are fixed
within a narrow range, with the majority being 11-13
nucleotides away in the top strand and 9-10 nucleo-
tides away in the bottom strand [24,25]. There was
an excellent correlation between hmDIP-Seq and Pvu-
Seq data; over 89% of the HMeDIP-Seq peaks were
also represented by Pvu-Seq peaks. An example of an
HMeDIP-Seq peak correlating with a Pvu-Seq reads in
AHB is shown in Figure 1b and c. These results confirm
the findings made with other techniques and indicate
that Pvu-Seq is a valid technique for mapping hmC sites
in the AHB and EHB genomes.
There are more non-CG modifications in genes with a low
CG content
Previous analyses in honey bees have shown that there
are two classes of genes with respect to CG methyla-
tion: one has a low observed over expected (o/e) CG
ratio (i.e., low CG content), is highly methylated, and is
enriched in housekeeping genes, and a second has a
high o/e ratio (i.e., high CG content), is unmethylated,
and is enriched in caste-specific and developmental genes
(Figure 2, dashed lines; Additional file 1: Figure S5)
[6,8,27-29]. Although non-CG sequences have a unimodal
distribution (Additional file 1: Figure S6), rather than a bi-
modal distribution in the genome, non-CG modifications
in introns surprisingly were found primarily in genes with
a low o/e CG ratio (Figure 2). Genes with greater than
10% non-CG modifications, such as mC and hmC, in in-
trons are primarily in low o/e CG genes (i.e., the left peak
in the o/e CG ratio plot, dashed lines; Figure 2), whereas
genes with zero percent non-CG modifications in introns
are in high o/e CG genes (i.e., the right peak in the o/e CG
ratio plot, dashed lines; Figure 2). Therefore, the pattern
of methylation is dependent on the CG dinucleotide
content and not the CHH or CHG trinucleotide con-
tent. We speculate that this might indicate that CG
Table 4 DNA methylation at CHG sites in AHB and EHB
AHB CHG methylation by genetic region
Type (alphabetical order) Analyzed Methylated Methylated %
Cds 1,002,706 3,493 0.35%
Downstream 1,119,219 4,559 0.41%
Exon 1,002,706 3,493 0.35%
Gene 3,188,727 11,619 0.36%
Intergenic 3,777,833 14,009 0.37%
Intron 2,225,532 8,217 0.37%
SpliceSiteAcceptor 16,858 43 0.26%
SpliceSiteDonor 4,407 15 0.34%
Transcript 3,470,589 12,577 0.36%
Upstream 1,189,498 4,526 0.38%
EHB CHG methylation by genetic region
Type (alphabetical order) Analyzed Methylated Methylated %
Cds 1,059,063 11,898 1.12%
Downstream 1,242,115 16,772 1.35%
Exon 1,059,063 11,898 1.12%
Gene 3,419,998 37,559 1.10%
Intergenic 4,099,352 45,117 1.10%
Intron 2,401,495 25,966 1.08%
SpliceSiteAcceptor 18,474 257 1.39%
SpliceSiteDonor 5,072 57 1.12%
Transcript 3,718,898 40,695 1.09%
Upstream 1,308,187 16,511 1.26%
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methylation is somehow linked to non-CG modifica-
tions, possibly via interactions between the maintenance
DNA methyltransferase, Dnmt1, and the de novo en-
zyme, Dnmt3, both of which are present in bees [5], and
the bee TET protein. In contrast to Dnmt1, which has
almost exclusive specificity for CG sites (however, see
ref. [30]), Dnmt3 is responsible for most non-CG
methylation in hESC [31]; this has not been examined
in bees.
CHH modifications are enriched in the introns of genes
that regulate transcription
We found that CHH modifications are highest in the in-
trons of genes in the GO category “regulation of tran-
scription” for both AHB and EHB (Figure 3a). This
includes several Homeobox transcription factors, such
as Distalless (Figure 3b) and aristaless (not shown). This
is in contrast to genes with the highest CG methylation
in exons, which were enriched in “housekeeping gene”
GO categories, such as mitochondrial, ribosomal, and
nucleotide-binding genes ([6,8,9] and data not shown).
As shown for Distalless (Figure 3b), introns in the “regu-
lation of transcription” GO category often had a large
amount of CG methylation in addition to the non-CG
modifications. This again suggests that CG methylation
and non-CG modifications are coordinately regulated.
Non-CG modifications might regulate alternative mRNA
splicing
Consistent with the idea that DNA methylation might
be involved in regulating mRNA splicing [8,9], we found
that splice donors and acceptors were often encoded by
DNA with non-CG modifications, such as either mC or
hmC. In bees and other invertebrates, over 90% of splice
donors have a G at the first position and a U at the sec-
ond position (i.e., 5’-AC-3’ on the template DNA strand,
where the C on the template strand can be methylated).
We identified several hundred modified cytosines at
splice donor and acceptor sites on the template strands
(346 mCs in 321 genes in AHB, and 1677 mCs in 1312
genes in EHB) (Figure 4a).
Based on the above numbers, only ~0.66% of the
~56,000 splice junctions were methylated in AHB (346)
and ~3.3% in EHB (1627) (Figure 4a). However, the dis-
tribution was clearly not random because pathway ana-
lyses show that genes with methylated splice sites were
most enriched in the GO pathway “phosphoprotein” in
both AHB and EHB (FDR < 10E-9 for both; Additional
file 2: Table S5). Intriguingly, the GO pathway “alterna-
tive splicing” was also significantly enriched in both
AHB and EHB (FDR < 0.05 for both; Additional file 2:
Table S5). For example, the honey bee gene that was
most heavily methylated at splice junctions is GB13778,
the ortholog of Drosophila dumpy, whose protein prod-
ucts are involved in cell adhesion in D. melanogaster
[33]; it has four methylated splice junctions in AHB and
twelve methylated splice junctions in EHB at CHH and
CHG sites (Figure 4b). Since dumpy has complex spli-
cing programs in Drosophila (16 distinct mature spliced
mRNAs are listed in FlyBase), and there are dozens of
dumpy exons in honey bees, it is attractive to speculate
that non-CG modifications at splice junctions in honey
bees regulate alternative splicing at this locus and others
as well.
In hESC lines, methylated non-CG sites are strongly
conserved especially within the motif 5’-TAmCAG-3’ on
the non-coding DNA strand at 3’ splice junctions [2].
While both hESCs and bees have non-CG modifications
at splice junctions, bees differ from hESCs in several
Table 5 Pvu-seq and HMeDIP-seq results show that
cytosine hydroxymethylation is enriched in introns in
the honey bee genome
Pvu-seq AHB
Type (alphabetical order) Count Percent
Downstream 114,800 10.50%
Exon 138,670 12.68%
Intergenic 367,126 33.58%
Intragenic 1,542 0.14%
Intron 245,458 22.45%
Splice_Site_Acceptor 46,519 4.25%
Splice_Site_Donor 46,039 4.21%
Upstream 133,265 12.19%
Pvu-seq EHB
Type (alphabetical order) Count Percent
Downstream 277,098 10.80%
Exon 312,968 12.20%
Intergenic 852,968 33.25%
Intragenic 3,332 0.13%
Intron 592,529 23.10%
Splice_Site_Acceptor 107,318 4.18%
Splice_Site_Donor 108,663 4.24%
Upstream 310,213 12.09%
HMeDIP-seq AHB
Type (alphabetical order) Count Percent
Downstream 2,255 10.98%
Gene 2,537 12.35%
Intergenic 6,312 30.72%
Intron 4,487 21.84%
None 2 0.01%
Splice_Site_Acceptor 1,343 6.54%
Splice_Site_Donor 1,373 6.68%
Upstream 2,238 10.89%
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Figure 1 Validation of CHH modifications based on MeDIP-Seq. a, A large MeDIP peak in Africanized honey bees (AHB) that has a large
amount of CHH modifications but no CG methylation in both European (EHB) and AHB. Coverage (0-181) represents the sequence coverage of
mDIP-Seq fragments (the gray line is 0 and the top of the peak is 181). Forward reads are shown in black and reverse reads are shown in gray.
The white boxes show reverse reads that did not have forward reads that could be aligned uniquely to the genome. The bottom portion shows
the CHH modifications in AHB and EHB. b, HMeDIP-Seq analysis of a region of the genome that has a large peak of immunoprecipitated DNA.
The histogram on the top shows the relative number of RNA-Seq fragments that align to the indicated region of the genome. Forward
sequences are shown in red and reverse sequences in blue. c, Pvu-Seq analysis of the same region of the genome. Notice the good concordance
between the two analyses.
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Figure 2 Cytosine modifications in introns are predominantly in the low-CpG content genes. a, plot of EHB genes (N = 514) with >90%
methylation at CpG sites. The dashed line shows the bimodal distribution of bee genes with low o/e and high o/e (observed/expected) CpG
ratios. The number of genes in the bimodal o/e plot is shown on the left Y-axis. The percentage of genes with >90% methylation in each region
of the bimodal o/e plot is shown on the right Y-axis. b, plot of EHB genes (N = 2912) with zero percent CpG methylation. Since there are a large
number of genes in all three classes with zero percent methylation, we restricted our analyses to genes with multiple motifs as follows: for CpG,
there are 2912 genes with at least 10 total CpGs in the exons with 0% methylation. c, plot of EHB genes (N = 615) with >10% methylation at
CHH sites in introns. d, plot of EHB genes (N = 555) with zero percent methylation at CHH sites in introns. For CHH, there are 555 genes with
zero percent methylation in introns that have at least 400 total CHHs in the introns. e, plot of EHB genes (N = 245) with >10% methylation at
CHG sites in introns. f, plot of EHB genes (N = 1364) with zero percent methylation at CHG sites in introns. For CHG, there are 1364 genes with
zero percent methylation with at least 100 total CHGs in the introns.
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Figure 3 CHH modifications are primarily in the introns of genes coding for transcription factors. a, EHB and AHB intron methylation at
CHH sites is enriched in the GO category “regulation of transcription” at the indicated FDR P values. There are 858 genes with >10% CHH
modifications in EHB and 529 genes with >5% CHH modifications in AHB. Analysis with DAVID [32]. b, Distalless is a Hox gene and a transcription
factor with high amounts of CHH modifications in the introns of both AHB and EHB.
Figure 4 Non-CpG methylation is enriched in splice junctions. a, In AHB, over 97% of splice donors that are methylated on the template
strand have the sequence GU (i.e., 209/216 have the template sequence AmC) and over 98% of splice acceptors that are methylated on the
template strand have the sequence AG (i.e., 128/130 have the template sequence mCT). Similarly in EHB, over 99% of splice donors that are
methylated on the template strand have the sequence GU (i.e., 877/885 have the template sequence AmC) and over 99% of splice acceptors that
are methylated on the template strand have the sequence AG (i.e., 790/792 have the template sequence mCT). b, dumpy is a gene with the
largest amount of splice junction methylation in both EHB (12 sites) and AHB (4 sites).
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respects. In hESCs, methylation is symmetrical at CAG
sites on both the template and non-template strand only at
the 3’ splice junction, which is most frequently CAG. How-
ever in bees, methylation was primarily asymmetrical at
CHH sites at the +1 position on the template strand encod-
ing splice acceptors and the -1 position on the template
strand at splice donors, and very few of the CHG sites in
bees were symmetrically modified (Table 2). Another differ-
ence between hESC and bees is that the 3’ splice sites are
predominantly methylated in humans but both 5’ and 3’
splice sites were modified in bees (Figure 4).
Genes with more CHH modifications in EHB than AHB are
enriched in behavioral response genes
Genes with significantly more CHH modifications in
EHB than AHB were enriched in GO categories that are
involved in neurological functions, such as “response to
external stimulus”, “substrate specific channel activity”,
“exocytosis”, and “neurotransmitter receptor activity”
(Additional file 2: Table S6). These categories were
highly significant even after correcting for the higher
overall CHH modifications in EHB as well as multiple
testing using the false discovery rate method (Additional
file 2: Table S6) [20]. It is attractive to speculate that dif-
ferential CHH modifications in introns might partially
explain the striking behavioral differences between AHB
and EHB, especially in aggression, but this is beyond the
scope of the present study. Genetic studies suggest epi-
genetic regulation of aggression in vertebrates [34-38],
and there are extensive aggression-related differences in
brain gene expression between the aggressive AHB and
the less-aggressive EHB [39]. Since there also are devel-
opmental differences between AHB and EHB, in
addition to differences in aggressive behavior, these two
types of differences would need to be teased apart in fu-
ture studies.
Gene expression positively correlates with both mC and
hmC levels in the exons
We found a weak, but significant correlation between
exon methylation and exon expression. This result was
obtained for methylation detected by either bisulfite se-
quencing or Pvu-Seq (Additional file 1: Figure S9). This
correlation was stronger for CG methylation than non-
CG.
Exons and Splice junctions with mC or hmC appear to
affect alternative mRNA splicing
As stated above, several studies have suggested that
DNA methylation might be involved in regulating
mRNA splicing. To determine how our new hmC finding
might influence our understanding of the relationship
between DNA methylation and mRNA splicing, we ana-
lyzed exons and splice junctions that differ in either mC
or hmC between AHB and EHB and compared this with
RNA-Seq data that we generated from AHB and EHB
brains. We found several examples of differential mC
and hmC associated with alternative mRNA splicing, as
described below.
Consistent with previous reports, we found several ex-
amples of differential CG methylation associated with al-
ternative mRNA splicing (Figure 5a). Consistent with
previously published examples [6], CG methylation in
DNA encoding exons often correlated with that exon be-
ing skipped. For example, for gene GB15706, we ob-
served that a heavily methylated exon in AHB was
skipped, whereas an adjacent heavily methylated exon in
EHB was skipped (see Additional file 1: Figure S8). We
also report for the first time that non-CG modifications,
such as hmC, also showed a correlation with alternative
splicing (Figure 5b). For example, the gene GB18247 had
hmC on an exon in AHB and that exon was retained in
AHB, but that same exon did not have hmC on it in EHB
and that exon was skipped. In other words, at least for
these examples, mC on exons correlated with exon skip-
ping, whereas hmC on exons correlated with exon
retention.
Conclusions
Our findings underscore the diversity of DNA methyla-
tion mechanisms that exist. Non-CG modifications were
only recently discovered in hESC and now we report
them in the distantly related honey bee. We speculate
that cytosine methylation at exons and splice junctions
on the DNA might affect the mRNA splicing machinery.
It is important to learn how these mechanisms work in
relation to known regulators of splicing, such as histone
acetylation [40], histone 3 lysine 4 methylation [41], his-
tone 3 lysine 36 methylation [42], and histone 3 lysine 9
methylation [43,44].
Understanding how non-CG hydroxymethylation might
affect alternative splicing is an exciting new area of re-
search. Our data are consistent with a model in which
DNA is methylated at CG sites by the maintenance DNA
methyltransferase, Dnmt1, at exons, and at non-CG sites
by the de novo DNA methyltransferase, Dnmt3, at introns.
In contrast to Dnmt1, mammalian Dnmt3 is known to
methylate both CG and non-CG sites in mammalian stem
cells [31]. We speculate that the honey bee TET enzyme
primarily recognizes the non-CG sites in the introns,
thereby enriching DNA hydroxymethylation in the in-
trons. We further speculate that the mRNA splicing ma-
chinery, as well as the histone modification machinery,
distinguishes exons and introns by somehow recognizing
the patterns of CG methylation in exons and non-CG
hydroxymethylation in introns.
Our identification of GO categories related to pro-
tein phosphorylation that were enriched for genes with
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methylated splice junctions is consistent with a similar
finding in a recent study of species-specific alternative
exons [45]. The authors present evidence that argues
that alternative splicing is used to alter protein phosphor-
ylation, which can alter protein stability, subcellular
localization, activity, and other properties [45]. Further re-
search is needed to determine the mechanism by which
splice junction methylation and hydroxymethylation affect
mRNA splicing.
Methods
Sequencing
All sequencing was performed using Illumina Genome
Analyzer GAIIx with a Paired End Cluster Generation Kit.
Image analysis, base calling and sequence extraction was
performed using standard Illumina Pipeline v1.6 software.
We performed whole-genome shotgun sequencing of
bisulfite modified DNA (BS-Seq). DNA sequencing (>20×
coverage) also was performed to ensure that the C to U
conversions were BS induced, rather than natural single
nucleotide polymorphisms (SNPs; not presented here).
BS-Seq was performed on Africanized honey bees (AHB)
(Apis mellifera scutellata) and European honey bees
(EHB) (a mixture of subspecies, primarily A.m. ligustica).
The number of lanes sequenced was 11 (pair-end reads)
for AHB and 8 for EHB, resulting in 240 million reads for
AHB and 317 million reads for EHB. Reads were 76 base-
pair long yielding a total of 18.2 giga bases and 24.1 giga
bases for AHB and EHB respectively. We note that we
used the Illumina Whole Genome Bisulfite Sequencing
(WGBS) kit which first ligates non-methylated primers
to the genomic DNA prior to bisulfite conversion. After
bisulfite conversion, a second set of primers are used
that only amplify the fully converted primers (e.g., [46]).
We confirmed that only fully-converted primers were
amplified in the BS-seq libraries (not shown).
Bioinformatics analysis
The bioinformatics analysis was conducted by two differ-
ent groups (D.M.R. and S.Z.), using different approaches
and without sharing any processed data or results.
Method 1 (BS-Miner)
The reference genome was Amel2, which is ~228 million
bases long. At the time we performed our first bisulfite
sequencing data analysis, there were only a few BS-Seq
mappers available and some of them had a tendency to
filter out non-CG methylation. For that reason, we de-
cided to create our own unbiased analysis pipeline,
which we called BS-Miner. It should be noted that now-
adays many more options exist and those early mappers
have been greatly improved, so there is no longer need
Figure 5 Non-CG cytosine modifications might affect alternative mRNA splicing. a, top blue lines indicated alternatively spliced exons in
AHB and EHB. Underneath the exon sequences are the BS-Seq results showing the locations of CpG, CHG, and CHH mC sites. Note that mC in an
exon correlates with the skipping of the exon by alternative splicing. For example, the gene GB15706, which encodes a homolog to Chromatin
assembly factor 1 subunit A (CAF1A), has heavy CpG, CHH, and CHG methylation in a downstream exon that is skipped in AHB and present in
EHB. Conversely, this gene has heavy cytosine methylation in the upstream exon in EHB that is skipped in EHB but present in AHB. Details of the
RNA-seq analyses is in Additional file 1: Figure S7. b, Top blue lines indicated alternatively spliced exons in AHB and EHB, The red-and-blue
stacked lines underneath the exons show Pvu-Seq analyses of AHB and EHB heads. Note that hmC also correlates with alternative mRNA splicing,
but in manners that differ from mC (see text). Details of the RNA-seq analyses are given in Additional file 1: Figure S7.
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to develop ad hoc methods. Read mapping and down-
stream analysis was done using BS-Miner. One of our
main biological questions was whether non-CG methyla-
tion was present or not so we designed our pipeline
using statistical methods well known in standard base
calling algorithms. As a result, we obtain better sensitiv-
ity but only on 100%, 50% or 0% methylation levels (that
is: methylated, hemi-methylated or no methylation). This
sensitivity comes at a cost. As expected, the method
does not detect methylation as a continuous range (from
0% to 100%) like other algorithms do. This design trade-
off was aligned with our research hypothesis.
BS-Miner uses either BWA [47,48] or Bowtie [49] for
read alignment. Both alignment programs are based on
the Burrows-Wheeler [50] transformation and create
SAM output format [51]. There are other tools and
methods based on similar approaches [21,22,52]. In this
case BWA was selected as the main mapping method in
order to have better alignment near insertions and dele-
tions. BS-Miner performs methylation calls by invoking
Samtools [51], which uses a probabilistic model [53]. It
must be noted that the BAQ model is explicitly disabled
by BS-Miner, since some of its assumptions do not apply
to methylation calls.
The BcfTools package was invoked to produce methy-
lation calls in VCF format. BS-Miner was set to filter out
low quality (Q < 20) methylation calls. After all mapping
and filtering steps, the mean coverage was 20.8 and 27.4
for AHB and EHB respectively, which is > 2-fold more
coverage than the previously most comprehensive bee
study [5]. As a final step, BS-Miner performs several
statistical analyses of the methylation results, including
ranking of hypo-methylated and hyper-methylated genes
by means of the Wilcoxon rank test and Fisher’s exact
test. Multiple testing was corrected using False Discov-
ery Rate methodology [20]. Some additional statistics
were carried out using custom programs in R program-
ming language [54] Further statistics from BS-Miner as
well as additional analysis are available at www.mcb.mc
gill.ca/~pcingola/bees/.
We also performed reanalysis of our data using Bowtie
and a pipeline similar to the one shown in Krueger et al.
[55]. Read trimming was performed using Trimmomatic
[56]. Quality control was performed using FastQC (http://
www.bioinformatics.babraham.ac.uk/projects/fastqc/) and
in-house software. Performing reanalysis using different
pipelines (BS-Miner and Bismark [21]) and different filter-
ing strategies, we obtained consistent results. Removing du-
plicates using Bismark’s remove duplicates module [21], did
not seem to change our results significantly.
Method 2 (BSMap)
Using standard software, BSMap [23], we obtained re-
sults consistent with previous studies: methylation was
primarily at CG dinucleotides in exons and very little
non-CG methylation was present (Additional file 1:
Figure S1a). There were 61,149,121 uniquely mapped cy-
tosines (Cs) in EHB and 53,443,185 in AHB. More than
88% of EHB Cs and 83% of AHB Cs were covered by at
least two sequencing reads (Additional file 1: Figure S2).
However, when we included the reads that have DNA
methylation in a non-CpG context, we found consider-
able amounts of CHH and CHG methylation (Additional
file 1: Figure S1b). Bisulfite reads were mapped with
BSMap to distinguish the methylated cytosine from
unmethylated cytosines. The reads of bisulfite converted
DNA were mapped to Apis mellifera genome assembly 4
after converting the Cs to Ts. Two mismatches were
allowed for the alignment to be made. To reduce the po-
tential erroneous cytosine methylation reads, the read
for a cytosine was discarded if there was a mismatch
event within the 2-bp surrounding context. There was
also another “CHH-filter” which filtered out the entire
read if the read contains three consecutive methylated
CHH. The analyses are presented in two ways: with
CHH-filter and without. For every gene, its 3k upstream
region, 3k downstream region, and every exon or intron
was divided into 30 bins and the ratio of the number of
methylated cytosines over the number of all cytosines
was plotted against the bin number. Bins were graphed
from upstream (relative to the gene) to downstream.
Comparison of methylation in AHB and EHB
The cytosine methylation in 3k upstream of all genes was
averaged to calculate "upstream" methylation levels for
every gene in both AHB and EHB; the cytosine methylation
levels in gene body (or exons) were averaged to calculate
the methylation level of gene body (or exons). To reduce
bias from low mapping coverage, genes with less than 100
cytosines covered by BS-Seq reads, in gene body and 3k up-
stream, were excluded.
Validating BS-Seq with MeDIP-Seq and HMeDIP-Seq
analyses
Methylated DNA immunoprecipitation followed by se-
quencing (MeDIP-Seq or HMeDip-Seq) was performed
for a total of 41.3 million 76 bp reads. Reads were
aligned using BWA and SamTools. Peak-calling was
performed using MACS 1.4 [57] beta version. Genomic
DNA from 3 AHB and 3 EHB heads was sheared to
300-600 bp fragments, gel purified, immunoprecipitated
with antibody, ligated to the library primers, amplified,
and then sequenced. The mC antibodies were mouse
monoclonal (Active Motif, Inc.) and the hmC antibodies
were rabbit polyclonal (Active Motif, Inc.). Immunopre-
cipitation was with protein G beads (Active Motif, Inc.)
following the manufacturer’s protocol. Additional file 1:
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Figure S4a shows the peak model based on the “forward
reads” [those that align with the “Watson” (plus) strand]
and the “reverse reads” [those that align with the “Crick”
(minus) strand].
Differential methylation analyses
Counts of methylation sites per gene, transcript, intron,
splice sites and other regions of interest were calculated.
Gene orthologs were calculated by InParanoid [58,59].
Enrichment was calculated using a greedy Wilcoxon
rank sum method, RssGsc (www.rssgsc.sourceforge.net),
which also performs multiple testing correction using
false discovery rate. Fisher’s exact test was also applied
as a secondary method, by setting a suitable threshold in
the ranked list.
Differencial SNP analysis
Counts of SNPs sites per gene, transcript, intron, splice
sites and other regions of interest were calculated.
Quantile normalization was applied and ranked genes
analyzed for enrichment using the same methods as de-
scribed in the previous section.
Observed over expected (o/e) analysis
The observed over expected ratio is defined as the num-
ber of CG dinucleotides in the reference sequence, di-
vided by the number expected under a uniform random
distribution. For genes having multiple transcripts
(which are a minority in amel2 reference genome), a
weighted average was calculated according to each tran-
script’s length. This definition is consistent with [60].
Accession numbers for data
The next-generation DNA sequencing experiments were
done by the Applied Genomics Technology Core at
Wayne State University. The next-generation DNA se-
quencing data (RNA-seq, Pvu-seq, MeDIP-seq, BS-seq,
and HMeDIP-seq) was deposited into the GEO database
according to the MINSEQE standards (Minimum Infor-
mation about a high-throughput SeQuencing Experi-
ment). The GEO database accession number is
GSE50990. Gene Expression Omnibus (GEO; http://
www.ncbi.nlm.nih.gov/projects/geo/).
Animal use ethical use issues
Honey bees are not a regulated invertebrate. Therefore,
no ethical use approval is necessary.
GEO accession number
(GSE50990; http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GSE50990).
Additional files
Additional file 1: Website of Data for Genome Browsers
(Maintained by PC): http://www.mcb.mcgill.ca/~pcingola/bees/.
Figure S1. Coverage of BS-Seq data. Figure S2. BSMap analysis of BS-
Seq data in AHB and EHB. Figure S3. Coverage by chromosome in AHB
and EHB. Figure S4. Honey bees have hydroxymethylcytosine, as
determined with dot blots. Figure S5. CpG methylation is highest in the
exons of housekeeping genes. Figure S6. Differential CHH modifications
is primarily in the introns of neuronal genes. Figure S7. RNA-Seq analysis
of AHB and EHB heads compared with BS-Seq analyses. Figure S8. RNA-
Seq analysis of AHB and EHB heads compared with Pvu-Seq analyses.
Additional file 2: Table S1. BS-Miner analyses of data from Lyko et al.
[6]. Table S2. BS-Map analysis of data from Lyko et al. [6]. Table S3.
Cytosine DNA methylation in EHB and AHB in CG, CHG, and GHH
genomic contexts. Table S4. Housekeeping genes have the most CpG
DNA methylation. Table S5. AHB and EHB genes with methylated splice
junctions. Table S6. Differential CHH modifications are in enriched in the
introns of neuronal genes.
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